Stefanie Puglielli, PhD, CMPP

Vice President, Scientific Services at OrtleyBio, a Red Nucleus Company
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Boulder, Colorado, United States, US
Languages
  • English Native or bilingual proficiency
  • Spanish Limited working proficiency
  • German Elementary proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Credentials

  • Certified Medical Publication Professional (CMPP)
    ISMPP (International Society for Medical Publication Professionals)
    Oct, 2018
    - Sep, 2024

Experience

  • OrtleyBio, a Red Nucleus Company
    • United States
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Vice President, Scientific Services
      • Feb 2022 - Present

    • Associate Vice President, Scientific Services
      • Nov 2020 - Feb 2022

  • Envision Pharma Group
    • United Kingdom
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Scientific Director
      • Jan 2020 - Nov 2020

    • Senior Medical Writer
      • Aug 2017 - Jan 2020

  • Truven Health Analytics, an IBM Company
    • Senior Research Analyst
      • Aug 2016 - Aug 2017

  • Aegis Creative
    • United States
    • Advertising Services
    • Medical Writer
      • Mar 2015 - Aug 2016

  • Truven Health Analytics
    • United States
    • 1 - 100 Employee
    • Clinical Writer
      • Jun 2014 - Mar 2015

  • University of Colorado Boulder
    • United States
    • Higher Education
    • 700 & Above Employee
    • Graduate Research Assistant (Tin Tin Su Laboratory)
      • Jun 2010 - Jun 2014

      (1) Examined the molecular and cellular mechanism of a protein synthesis inhibitor in combination with ionizing radiation (IR) in a head and neck cancer cell line• Performed biochemical assays to examine the ability of the drug to target the ribosome• Determined effective combinations of drug and IR in head and neck cancer cells• Utilized apoptotic, proliferative, and senescence assays to determine effects of treatment (2) Examined whether isogenic tumors in separate tissues behave and respond to treatments similarly in Drosophila melanogaster• Identified cell-type origin of gonad tumors• Performed microsopy to examine differences in isogenic cephalic and gonad neoplasms• Utilized immunohistochemistry techniques to examine tumor responses to treatment

  • The Wistar Institute
    • United States
    • Research Services
    • 200 - 300 Employee
    • Undergraduate Research Assistant (Anthony Capobianco Laboratory)
      • Dec 2006 - May 2009

      • Mutagenesis of phosphorylation sites on the intracellular portion of Notch to determine vital residues involved in the Notch-CSL interaction and activation of Notch target genes• Mutation and purification of Mastermind, a protein involved in the Notch signaling pathway • Mutagenesis of phosphorylation sites on the intracellular portion of Notch to determine vital residues involved in the Notch-CSL interaction and activation of Notch target genes• Mutation and purification of Mastermind, a protein involved in the Notch signaling pathway

Education

  • University of Colorado Boulder
    Doctor of Philosophy (Ph.D.), Molecular, Cellular, Developmental Biology
    2009 - 2014
  • University of Pennsylvania
    Bachelor of Arts (B.A.), Biochemistry
    2005 - 2009

Community

You need to have a working account to view this content. Click here to join now